Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
1mon
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each ...
Next-generation sequencing (NGS) has transformed genomic research and clinical diagnostics by enabling rapid, high-throughput analysis of genetic material. The application of NGS to formalin-fixed ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Josh Lauer explores the trends shaping sequencing, the science behind SBX technology, and how AXELIOS 1 is designed to ...
The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results